These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12172393)

  • 1. High "population attributable fraction" for coronary heart disease mortality among relatives in monogenic familial hypercholesterolemia.
    Austin MA; Zimmern RL; Humphries SE
    Genet Med; 2002; 4(4):275-8. PubMed ID: 12172393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
    Humphries SE; Cooper JA; Seed M; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil HAW;
    Atherosclerosis; 2018 Jul; 274():41-46. PubMed ID: 29751283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register.
    Humphries SE; Cooper JA; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil AHW;
    Atherosclerosis; 2019 Feb; 281():207-212. PubMed ID: 30458964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A suggestion for familial hypercholesterolemia (FH) heterozygosity clinical diagnosis based on epidemiological observations in a large Italian population.
    Cicero AFG ; Braiato A; D'Addato S; Sangiorgi Z; Gaddi A
    Int J Cardiol; 2000 Jun; 74(1):5-11; discussion 13-4. PubMed ID: 10854674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk.
    Séguro F; Rabès JP; Taraszkiewicz D; Ruidavets JB; Bongard V; Ferrières J
    Clin Cardiol; 2018 Mar; 41(3):385-391. PubMed ID: 29574850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease.
    Melnes T; Bogsrud MP; Christensen JJ; Rundblad A; Narverud I; Retterstøl K; Aukrust P; Halvorsen B; Ulven SM; Holven KB
    Atherosclerosis; 2024 May; 392():117507. PubMed ID: 38663317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
    Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary risk factors in adolescents related to their knowledge of familial coronary heart disease and hypercholesterolemia: the Muscatine Study.
    Muhonen LE; Burns TL; Nelson RP; Lauer RM
    Pediatrics; 1994 Mar; 93(3):444-51. PubMed ID: 8115204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.
    Versmissen J; Oosterveer DM; Yazdanpanah M; Dehghan A; Hólm H; Erdman J; Aulchenko YS; Thorleifsson G; Schunkert H; Huijgen R; Vongpromek R; Uitterlinden AG; Defesche JC; van Duijn CM; Mulder M; Dadd T; Karlsson HD; Ordovas J; Kindt I; Jarman A; Hofman A; van Vark-van der Zee L; Blommesteijn-Touw AC; Kwekkeboom J; Liem AH; van der Ouderaa FJ; Calandra S; Bertolini S; Averna M; Langslet G; Ose L; Ros E; Almagro F; de Leeuw PW; Civeira F; Masana L; Pintó X; Simoons ML; Schinkel AF; Green MR; Zwinderman AH; Johnson KJ; Schaefer A; Neil A; Witteman JC; Humphries SE; Kastelein JJ; Sijbrands EJ
    Eur J Hum Genet; 2015 Mar; 23(3):381-7. PubMed ID: 24916650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemia.
    van der Net JB; Janssens AC; Defesche JC; Kastelein JJ; Sijbrands EJ; Steyerberg EW
    Am J Cardiol; 2009 Feb; 103(3):375-80. PubMed ID: 19166692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China.
    Jin W; Zhang Q; Wang B; Pan L; Qin H; Yang D; Zhou X; Du Y; Lin L; Kutryk MJ
    BMC Med Genet; 2019 Nov; 20(1):173. PubMed ID: 31706281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
    Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
    Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of death in patients with familial hypercholesterolemia.
    Mabuchi H; Miyamoto S; Ueda K; Oota M; Takegoshi T; Wakasugi T; Takeda R
    Atherosclerosis; 1986 Jul; 61(1):1-6. PubMed ID: 3730050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis for coronary heart disease in heterozygote familial hypercholesterolemia patients.
    Sánchez Muñoz-Torrero JF; Rivas MD; Zamorano J; Joya-Vázquez PP; de Isla LP; Padro T; Mata P; The Safeheart Investigators
    Per Med; 2018 Mar; 15(2):87-92. PubMed ID: 29714125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart disease.
    Real JT; Ascaso JF; Chaves FJ; Tenés S; Priego MA; Puig O; Armengod ME; Carmena R
    Nutr Metab Cardiovasc Dis; 1999 Feb; 9(1):41-4. PubMed ID: 10726108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.